Acadia Pharmaceuticals Inc (ACAD): Free Cash Flow
$105.15M
Year ended 2025-12-31
$145.62M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $105.15M | -33.1% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $157.20M | +844.0% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $16.65M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$114.03M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$126.78M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$143.75M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$152.26M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$169.57M | n/c | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$218.57M | n/m | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | -$209.91M | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2011-12-31 and 2016-12-31. | |||
| 2011-12-31 | -$19.90M | n/a | 2014-02-27, From 2011-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $105.15M | -33.1% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $246.45M | +1.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$190.02M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$320.03M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$93.00M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $171.39M | +258.7% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $347.89M | +59.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $156.89M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $327.58M | +61.1% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗